30 closest matches · ranked by relevance
Chronic Disease · Frail · Diabetes Mellitus
Primary: Feasibility - Recruitment — 9; 15; 9; 11 # of participants @ start of study
Obesity · Sedentary Lifestyle · Insulin Resistance
Primary: Change in Weight — 0.7; -1.5 kg — p=0.256
Physical Activity
Primary: Total Physical Activity — 34.21; 37.80; 39.42 total metabolic equivalent
Cancer · Hypertension · Diabetes
Primary: Change in Fatigue as Assessed by Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0-Fatigue 6a — -1.61; 4.26 T-score
Mild Cognitive Impairment · Cognitive Decline · Memory Impairment
Primary: ADAS-Cog-Exec Global Composite — -0.146; -0.068 Change score — p=0.29
Childhood Obesity
Primary: Change From Baseline to After Intervention in 75 Foot Laps Completed in 2 Minutes — -0.08; 0.53 Difference in Laps Completed
Metabolic Syndrome
Primary: Maximal Oxygen Uptake — 18.3; 15.8; 18.6; 14.4 ml/kg/min
Spinal Cord Injuries
Primary: Physical Activity Level at Week 8 — 383; 297 Minutes per week
Type 2 Diabetes Mellitus · Cognitive Impairment · Non-insulin-dependent Diabetes Mellitus
Primary: Change in Cognitive Function Based on Risk Stratification Score (RSS) — -0.2; -0.1; -0.8; 0.0 score on a scale
Depression · Osteoarthritis
Primary: Attendance of the Fit & Strong! Intervention Classes — 10 Classes attended
Osteoarthritis, Knee
Primary: Change in Lower Extremity Function — 10.6; 7.6; -6.4 Change in scores on a scale
Healthy Cognition
Primary: Rey Auditory Verbal Learning Test Sum of Trials 1-5 — 49.7; 47.6; 51.6; 49.4 Sum of words recalled Trials 1 to 5
Obesity
Primary: Weekly Moderate-Vigorous Physical Activity Minutes, Accelerometry — -21.4286; -53.9600; 19.6000; -38.6800 Minutes
End-stage Liver Disease (ESLD) · Liver Transplant · Sarcopenia
Primary: Physical Fitness - VO2 — -1; -3 mL oxygen/kg/min — p=0.49
Physical Activity · Obesity
Primary: Pre-exercise Affect (Session 1) — 3.97; 2.70 units on a scale
Hypertension With Complications and Secondary Hypertension · Overweight and Obesity · Lipid Metabolism Disorders
Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants
Breast Cancer Female
Primary: Session Attendance — 39 Participants
Diabetes Mellitus · Obesity · Paraplegia
Primary: Change in % Body Fat — -1.83; -1.68 Percent Body Fat — p=>0.05
Peripheral Arterial Disease
Primary: Difference in Time to Onset of Calf Pain (Claudication Onset Time) Pre-intervention to Post-intervention — 396; 140 seconds — p=0.028
Central Obesity · Obesity
Primary: Change in Waist Circumference — -1.3; -1.9; -4.1 cm — p=0.074
Hypertension
Primary: 7-Day Physical Activity Recall (7-Day PAR) — 54.85; 44.89 minutes
Breast Neoplasm · Physical Activity
Primary: Acceptability: Percent of Eligible Patients That Provide Consent and Are Enrolled in the Study. — 19 Participants
Chronic Kidney Disease
Primary: Change in Proteinuria — -34; -133 mg/g creatinine — p=0.04
Breast Cancer
Primary: Missed Fractions
Breast Cancer
Primary: Change in Cognitive Function — -0.05; 0.01; 0.21; 0.17 z-score
Diabetes Mellitus Type 2
Primary: Comfortable Gait Speed — 1.2; 1.2 meters per second — p=0.16
Heart Failure, Diastolic · Obesity
Primary: Peak Exercise Oxygen Consumption (VO2) — 1609; 1653 ml/min — p=0.21
Rheumatoid Arthritis
Primary: Metabolic Syndrome Severity Z-score (MSSc) — -1.89; -1.82; -3.23; -3.49 Z-score (unitless) — p=<0.05
Hematopoietic and Lymphoid Cell Neoplasm
Primary: Number of Patients With Adverse Events (AE), Graded According to Common Terminology Criteria for Adverse Events Version 5.0 — 0 Participants
Physical Disability
Primary: Change in Self-reported Overall Function From Baseline to 12 Weeks — 0.4; -0.6; -1.37; -0.32 units on a scale — p=0.2691